Clinical trials
Liver Cirrhosis trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 7 |
| Unknown status | 4 |
| Terminated | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 4 |
| Maastricht University Medical Center | 3 |
| University Medical Center Groningen | 2 |
| AstraZeneca | 1 |
| Azienda Ospedaliera di Padova | 1 |
| Boehringer Ingelheim | 1 |
| Carmen Dietvorst | 1 |
| Cook Research Incorporated | 1 |
| Erasmus Medical Center | 1 |
| European Foundation for Study of Chronic Liver Failure | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liver Cirrhosis | 23 |
| Liver Diseases | 5 |
| Diabetes Mellitus, Type 2 | 3 |
| Fatty Liver | 3 |
| Fibrosis | 3 |
| Hypertension | 3 |
| Obesity | 3 |
| Ascites | 2 |
| Dyslipidemias | 2 |
| End Stage Liver Disease | 2 |
Trials
Showing 76 to 23 of 23. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.